Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Blood|November 11, 1999
Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2J Levin, J P Peng, G R Baker, et al.Journal of Cellular Physiology|January 1, 1988
Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta)M T Mitjavila, G Vinci, J L Villeval, et al.Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragmentsC Lecut, L A Feeney, G Kingsbury, et al.Leukemia|January 1, 1987
Expression of blood group A antigen during erythroid differentiation in A1 and A2 subjectsM Tulliez, J L Villeval, F Lejeune, et al.Blood|February 15, 1996
Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignanciesJ P Le Couedic, M T Mitjavila, J L Villeval, et al.Gene Therapy|June 6, 1998
Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppressionM A Abina, M Tulliez, C Lacout, et al.Anticancer Research|January 1, 1984
Characterization of phorbol esters binding to K 562 cellsF Louache, J L Villeval, P G Pelicci, et al.Leukemia|April 6, 2013
A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progressionC Marty, C Lacout, N Droin, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPOM A Abina, M Tulliez, M T Duffour, et al.Blood|November 1, 1986
Phenotype of early erythroblastic leukemiasJ L Villeval, P Cramer, F Lemoine, et al.Pageof 5